Minnetonka, MN, United States of America

Robert A Ganz

This inventor holds 29 USPTO granted patents and 19 published patent applications, plus 3 CIPO patents and 4 EPO patents, primarily in Gastrointestinal Treatment. Top assignees: Boston Scientific Scimed, Inc., Covidien LP, Eschara Medical, LLC. Active years: 1996-2024.

USPTO Granted Patents = 29 

% Patents Active = 65.5

 

 

Average Co-Inventor Count = 2.2

ph-index = 17

Forward Citations = 1,607(Granted Patents)


Location History:

  • Plymouth, MN (US) (2009)
  • Minneapolis, MN (US) (1996 - 2013)
  • Minnetonka, MN (US) (2004 - 2022)

Company Filing History:


Years Active: 1996-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Sphincter Disorders
Obesity Treatment
Gastroesophageal Reflux Disease
Blockage Removal
Abnormal Tissue Treatment
Atherosclerotic Vascular Disease
Microorganism Elimination
Endoscopic Probe
X-ray Device
Temperature Sensitive Storage
Incubation Apparatus
Sphincterotome
29 patents (USPTO):Explore Patents

Title: The Inventor Profile of Robert A Ganz

Introduction: Robert A Ganz is a renowned inventor based in Minnetonka, MN (US) known for his groundbreaking contributions to various fields.

Latest Patents: Robert A Ganz holds several patents in the areas of medical devices, consumer electronics, and sustainable energy solutions.

Career Highlights: With a career spanning over two decades, Robert A Ganz has established himself as a leading innovator in the industry, with a focus on developing cutting-edge technologies that have a positive impact on society.

Collaborations: Throughout his career, Robert A Ganz has collaborated with top research institutions, universities, and companies to bring his inventions to life and make a difference in the world.

Conclusion: Robert A Ganz's passion for innovation and his dedication to creating solutions for the future continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…